FridayJan 07, 2022 9:30 am

GreenBox POS (NASDAQ: GBOX) Is ‘One to Watch’

GreenBox POS reported $8 million in revenue for Q3 2021 on $540 million processed transaction volume GreenBox’s guidance for FY2022 forecasts processing volume of at least $4.9 billion The company’s planned spinoff of its coyni smart contract token technology is expected to accelerate revenue growth GreenBox shareholders will have an opportunity to benefit from dividends in the coyni spin off IPO The company’s Board of Directors recently approved a share buy-back program GreenBox POS (NASDAQ: GBOX) is an emerging financial technology company leveraging proprietary security and token technology to build customized payment solutions for business. The company’s mission is to build…

Continue Reading

FridayJan 07, 2022 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Receives Rave Reviews Following Debut at LA Auto Show; Mullen FIVE RS Aims to Be World’s Fastest EV

Mullen Automotive launched the Mullen FIVE EV Crossover at the recent LA Auto Show, with the vehicle winning the auto show’s ZEVA(R) award for top all-electric SUV The Mullen FIVE has seen a spike in popularity following its debut, with the carmaker recently opting to lift the initial reservation limit to 25,000 vehicles The future Mullen FIVE’s RS is being modeled to usurp Tesla Model S Plaid’s title as the world’s fastest EV, with the ability to accelerate from 0-62 mph in a mere 1.9 seconds Mullen Automotive has recently entered a partnership with Germany's ARRK to support the engineering…

Continue Reading

FridayJan 07, 2022 9:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Signs LOI with Maya to Co-Develop a Prescription Digital Therapeutics Platform Targeting a Trifecta Approach to Patient Care

Mydecine has signed a letter of intent with Maya detailing a collaborative partnership to develop a novel digital therapeutics (“DTx”) platform The DTx platform is expected to create a three-pronged approach to patient care by combining Mydecine’s Mindleap digital health platform with its medication-based treatments According to COO Damon Michaels, the new platform will provide improved adherence to treatment protocols, patient experience, biometric insights, and post-approval insurance reimbursements Both companies intend to pursue rigorous studies to achieve FDA clearance Regarded as the convergence of health care and software that has resulted in a new crop of life sciences technology helping…

Continue Reading

FridayJan 07, 2022 9:00 am

Sugarmade Inc. (SGMD) Subsidiary Obtains Permit, Takes Key Step Toward Commercialization

SGMD’s Lemon Glow receives conditional use permit number from county Sugarmade’s seed-to-door vision separates the company from other players in the California cannabis marketplace Estimated for Lemon Glow property could reach as much as 64 tons of dry trimmed cannabis flower annually Sugarmade (OTC: SGMD) is making significant progress toward its end goal of becoming a central play in the growing California cannabis space. The company announced that its wholly owned subsidiary, Lemon Glow Company, has received a conditional use permit (“UP”) number from the Community Development Department of the County of Lake, California (https://ibn.fm/zkjLq). The permit, noted Sugarmade, is…

Continue Reading

ThursdayJan 06, 2022 9:30 am

Cannabis Strategic Ventures Inc. (NUGS) Strengthens Foothold as Mounting Numbers Support Cannabis Legalization

An estimated 91% of U.S. adults (91%) say either that marijuana should be legal for medical and recreational use or that it should be legal for medical use only While cannabis remains an illegal substance federally, a growing number of states have legalized the substance An emerging leader in the U.S. cannabis marketplace, NUGS’ vision is to acquire, scale assets in the legal cannabis market A vast majority of adults in the United States say that marijuana should be legal for either medical and recreational use or at least for medical use, according to a recent Pew Research Center report (https://ibn.fm/zqnb9). Companies such as…

Continue Reading

ThursdayJan 06, 2022 9:30 am

InnerScope Hearing Technologies Inc. (INND) Completes Key Acquisitions as Hearing Aid Market Poised for DTC Transition in 2022

The World Health Organization estimates by 2050 nearly 2.5 billion people will have some degree of hearing loss and at least 700 million will require hearing rehabilitation InnerScope Hearing Technologies has made transformational moves in 2021 to position itself as a leader in direct-to-consumer (“DTC”) sales of hearing aids and related products InnerScope recently acquired Hearing Assist II, Walmart’s largest hearing aid provider, and iHEAR Medical, the maker of the only FDA-cleared home hearing screener, setting up for what expects to be a record Q4 2021 As our homes have become our offices, schools, restaurants, and more throughout the coronavirus…

Continue Reading

ThursdayJan 06, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key Meeting with UK Regulatory Agency

Meeting takes company a step closer to advancing its lead investigational candidate CYB003 into clinical development CYB003 is designed for the treatment of two significant conditions: major depressive disorder (“MDD”) and alcohol use disorder (“AUD”) CEO notes that CYB003 has the potential to achieve better patient outcomes The coming year holds significant promise for Cybin (NEO: CYBN) (NYSE American: CYBN) for numerous reasons. The biopharmaceutical company has seen significant success in the execution of its strategic focus on progressing psychedelics to therapeutics, including its recent announcement that company representatives will hold a scientific advice meeting with the UK Medical and Healthcare…

Continue Reading

ThursdayJan 06, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Increases Investor Visibility with SRAX Inc. (NASDAQ: SRAX)

The strategic move to incorporate SRAX is designed to bring investor visibility for all of the upcoming events that Lexaria has planned for 2022 Lexaria’s patented DehydraTECH(TM) technology is poised to leverage multiple industries – notably the CBD industry, with a projected value of $108.8 billion by 2027 The advertising and media contract will allow SRAX to engage and manage social media companies for the creation and distribution of advertising materials promoting Lexaria Bioscience Lexaria Bioscience (NASDAQ: LEXX), an innovator of drug delivery platforms, announced that it will kick off 2022 with an advertising and media agreement with SRAX (NASDAQ:…

Continue Reading

ThursdayJan 06, 2022 9:00 am

Friendable Inc.’s (FDBL) Fan Pass Live Platform Announces January Contest on Instagram; Winter Merchandise Collection Available in Dedicated Online Shop

Besides the monthly contest prizes, artists who promote three of their streams on Instagram and tag @fanpasslive have the opportunity to earn an additional $30 this month Fan Pass Live’s Winter Merchandise Collection is now available for purchase on the website – the merchandise is Fan Pass branded and features items like hoodies, socks, beanies, sweatpants, and more Fan Pass Live Artist Pro subscriptions are available for $8.99 per month and provide extra perks for artists on the platform Mobile technology and marketing company Friendable Inc.’s (OTC: FDBL) Fan Pass Live platform has released its January contest for artists. The…

Continue Reading

WednesdayJan 05, 2022 1:47 pm

SRAX Inc. (NASDAQ: SRAX) Set to Benefit as Analysts Hike Company’s Fourth Quarter Revenue Forecasts

Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth Zacks have also upped their fiscal year 2022 revenue forecast to $42.52 million, implying +35% YoY growth SRAX’s implied results look even more impressive given that it will no longer be consolidating the financials of key subsidiary, BIGtoken, following the latter company’s merger with BritePool, Inc SRAX’s future growth trajectory is set to be dictated by investor intelligence platform, Sequire, having recently recorded its twelfth consecutive quarter of revenue growth SRAX (NASDAQ: SRAX) a financial technology company that unlocks data and insights for…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered